Aurigene Discovery Technologies
在场
Aurigene Discovery Technologies 的所有者是 Dr. Reddy's.
是其中之一......
Dr. Reddy's 是一家在股票代码 DRREDDY (IN) 下上市的公司。
他们在：
涉及Dr. Reddy's的并购和融资。
- Mayne Pharma US and Dr. Reddy's have announced they will merge (公布2023二月28号)..
高管
查看带有其 16 名主要高管的组织结构图
Aurigene Discovery Technologies 搜索最多的简介
- Murali Ramachandra, Chief Executive Officer
- GV Prasad, Chairman of the Board
- Hariharnath Buggana, Independent Director
高管在Dr. Reddy's变化
- Milan Kalawadia 曾任 Chief Commercial Officer, North America Generics, 现升职为 Chief Executive Officer, North America (新闻发布的2024五月29号).
创建提醒
跟踪 Aurigene Discovery Technologies 的高管变动
生物技术
Dr. Reddy's 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
- Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
生物技术 行业的其他推荐联系人
消息
Aurigene Discovery Technologies 的最新新闻稿
- News Archives - Page 3 of 3 - Aurigene
- News Archives - Page 2 of 3 - Aurigene
- Development of Drugs and Pharmaceutical Industry | Aurigene Pharma
- News Archives - Aurigene
- Home
- Home
- Olema
- Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170 | Aurigene - Part 2
- Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170 | Aurigene
- Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170
- View more press releases Close
通过电子邮件
